Multiple sclerosis pathophysiology: Difference between revisions

Jump to navigation Jump to search
Ahmed Younes (talk | contribs)
No edit summary
Fahimeh Shojaei (talk | contribs)
No edit summary
Line 12: Line 12:


== Pathophysiology ==
== Pathophysiology ==
{{Main|Pathophysiology of multiple sclerosis}}
Although much is known about how multiple sclerosis causes damage, the reasons why multiple sclerosis occurs are not known.
Multiple sclerosis is a disease in which the [[myelin]] (a [[lipid|fatty]] substance which covers the [[axon]]s of [[neuron|nerve cells]]) degenerates. According to the view of most researchers, a special subset of [[lymphocyte]]s, called [[T cell]]s, plays a key role in the development of MS.
According to a strictly immunological explanation of MS, the inflammatory process is triggered by the T cells. T cells gain entry into the brain via the [[blood-brain barrier]] (a capillary system that should prevent entrance of T-cells into the nervous system). The blood brain barrier is normally not permeable to these types of cells, unless triggered by either infection or a virus, where the integrity of the [[tight junction]]s forming the blood-brain barrier is decreased. When the blood brain barrier regains its integrity (usually after infection or virus has cleared) the T cells are trapped inside the brain. These [[lymphocyte]]s recognize myelin as foreign and attack it as if it were an invading virus. That triggers [[inflammation|inflammatory]] processes, stimulating other immune cells and soluble factors like [[cytokine]]s and [[antibody|antibodies]]. Leaks form in the [[blood-brain barrier]]. These leaks, in turn, cause a number of other damaging effects such as [[edema|swelling]], activation of [[macrophages]], and more activation of cytokines and other destructive [[protein]]s such as [[matrix metalloproteinase]]s. A deficiency of [[uric acid]] has been implicated in this process.<ref>{{cite journal |author=Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, Dimitrakopoulos A, Karouli M, Vassilopoulos D |title=Serum uric acid and multiple sclerosis |journal=Clinical neurology and neurosurgery |volume=108 |issue=6 |pages=527-31 |year=2006 |pmid=16202511}}</ref>
It is known that a repair process, called remyelination, takes place in early phases of the disease, but the [[oligodendrocyte]]s that originally formed a [[myelin sheath]] cannot completely rebuild a destroyed myelin sheath. The newly-formed myelin sheaths are thinner and often not as effective as the original ones. Repeated attacks lead to successively fewer effective remyelinations, until a scar-like plaque is built up around the damaged axons, according to [[pathophysiology of multiple sclerosis#Demyelination patterns|four different damage patterns]].<ref>Lucchinetti, C. Bruck, W. Parisi, J. Scherhauer, B. Rodriguez, M. Lassmann, H.''Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination'' Ann Neurol, 2000; 47(6):707-17. PMID 10852536</ref> The central nervous system should be able to recruit oligodendrocyte [[stem cell]]s capable of turning into mature myelinating oligodendrocytes, but it is suspected that something inhibits stem cells in affected areas.
The [[axon]]s themselves can also be damaged by the attacks.<ref>{{cite journal |author=Pascual AM, Martínez-Bisbal MC, Boscá I,''et al'' |title=Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis |journal=Neurology|volume=69 |issue=1 |pages=63-7 |year=2007 |pmid=17606882 |doi=10.1212/01.wnl.0000265054.08610.12}}</ref> Often, the brain is able to compensate for some of this damage, due to an ability called [[neuroplasticity]]. MS symptoms develop as the cumulative result of multiple [[lesion]]s in the brain and [[spinal cord]]. This is why symptoms can vary greatly between different individuals, depending on where their lesions occur.
<gallery perRow="2">
Image:MS Demyelinisation KB 10x.jpg|Demyelinization in MS. On Klüver-Barrera myelin staining, decoloration in the area of the lesion can be appreciated (Original scale 1:100)
Image:Carswell-Multiple Sclerosis2.jpg|Detail of drawing from Carswell book depicting multiple sclerosis lesions in the [[brain stem]]and [[spinal cord]] (1838)
</gallery>
{{Neuron map|Myelin sheath of a healthy neuron}}


==References==
==References==

Revision as of 16:44, 23 January 2018

https://https://www.youtube.com/watch?v=yzH8ul5PSZ8 |350}}

Multiple sclerosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Multiple sclerosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT Scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Alternative Therapies

Primary Prevention

Secondary Prevention

Tertiary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Multiple sclerosis pathophysiology On the Web

Most recent articles

cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Multiple sclerosis pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Multiple sclerosis pathophysiology

CDC on Multiple sclerosis pathophysiology

Multiple sclerosis pathophysiology in the news

Blogs on Multiple sclerosis pathophysiology

Directions to Hospitals Treating Multiple sclerosis

Risk calculators and risk factors for Multiple sclerosis pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pathophysiology

References

Template:WH Template:WS